Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Micrologix Biotech advances development of antimicrobial peptides for treatment of eye infections

Sep. 14, 1998

Troponin I blocks retinal angiogenesis in another animal model

Sep. 11, 1998

IND application for NeXstar antiangiogenesis drug approved by FDA

Sep. 4, 1998

PMA for KeraVision Ring accepted for filing

Sep. 3, 1998

IL-1 blockers CK-119 and CK-122 inhibit corneal fibroblast-like cell proliferation

Aug. 28, 1998

Future antiglaucoma drug candidates added to the pipeline at Alcon

Aug. 24, 1998

PGF2alpha derivative from Allergan reduces ocular hypertension in monkeys

Aug. 20, 1998

Sugen reaches milestone in collaborative agreement with Allergan

Aug. 10, 1998

First SELEX compound from NeXstar heads for clinical trials in ARMD

July 27, 1998

Troponin I inhibits retinal angiogenesis in animal studies

July 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...